Atlas Trials

Remifentanil Intravenous Patient Controlled Analgesia (IVPCA) for Ablation of Idiopathic Ventricular Tachycardia

Clinical trial NCT01901575 · COMPLETED

Trial details

NCT number
NCT01901575
Sponsor
NYU Langone Health
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
Tachycardia, Ventricular
Start date
2011-07-01
Primary completion
2013-04-01
Enrollment
16

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.